serine/threonine Kinase 17b (STK17B) (C-Term) Peptide

Details for Product No. ABIN1382031
Request Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

Protein Name
Synonyms DRAK2, Drak2, 3110009A03Rik, AI120141, zgc:65989, STK17B
Protein Region
C-Term
Origin
Human
(1)
Application
Blocking Peptide (BP)
Pubmed 1 reference available
Catalog no. ABIN1382031
Quantity 0.05 mg
Price
77.00 $   Plus shipping costs $45.00
Shipping to United States (Change)
Availability Will be delivered in 2 to 3 Business Days

Order hotline:

  • +1 404 474 4654
  • +1 888 205 9894 (TF)
Characteristics 15 amino acids near the carboxy terminus of human DRAK2.
Human
Alternative Name DRAK2
Research Area Signaling, Apoptosis/Necrosis
Application Notes DRAK2 peptide is used for blocking the activity of DRAK2.
Restrictions For Research Use only
Format Liquid
Concentration 200 µg/mL
Buffer PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1 % bovine serum albumin and 0.02 % sodium azide
Preservative Sodium azide
Precaution of Use This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage -20 °C
Expiry Date 12 months
Background publications Sanjo, Kawai, Akira: "DRAKs, novel serine/threonine kinases related to death-associated protein kinase that trigger apoptosis." in: The Journal of biological chemistry, Vol. 273, Issue 44, pp. 29066-71, 1998 (PubMed).

Reactivities (1)
Request Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

Order hotline:

  • +1 404 474 4654
  • +1 888 205 9894 (TF)
Validation Images
back to top